Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nice Ltd

148.26
+3.642.52%
Post-market: 148.260.00000.00%19:55 EST
Volume:630.73K
Turnover:92.71M
Market Cap:9.32B
PE:21.93
High:148.75
Open:144.25
Low:144.06
Close:144.62
Loading ...

NICE Ltd. (NICE): Why Should You Invest In This Undervalued Tech Stock Now?

Insider Monkey
·
22 Jan

Cantor Fitzgerald Initiates NICE at Neutral With $176 Price Target

MT Newswires Live
·
17 Jan

Santhera Receives Positive NICE Final Guidance for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

GlobeNewswire
·
16 Jan

NICE vs. PYCR: Which Stock Should Value Investors Buy Now?

Zacks
·
16 Jan

Should You Hold NICE Stock Despite 20% Decline Over the Past Year?

Zacks
·
15 Jan

NICE Opens Nominations for 2025 PSAPs’ Finest Awards Recognizing Emergency Communications Standouts

Business Wire
·
13 Jan

Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment

GlobeNewswire
·
08 Jan

San Francisco Department of Emergency Management Selects NICE Inform Elite for Capturing and Analyzing 911 Communications

Business Wire
·
08 Jan

Creand Crèdit Andorrà Partners with NICE Actimize to Upgrade AML Strategy

TIPRANKS
·
08 Jan

NICE Actimize Partners with The Knoble Non-Profit Network to Issue Best Practices Guide for Identifying Human Trafficking Activity

Business Wire
·
07 Jan

NICE Ltd. (NICE) Downgraded: What Does CEO Transition Mean for Growth?

Insider Monkey
·
31 Dec 2024

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

GlobeNewswire
·
27 Dec 2024

Press Release: Outlook Therapeutics(R) Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

Dow Jones
·
27 Dec 2024

Genedrive’s CYP2C19-ID Kit Outperforms Traditional Testing, Gains NICE Endorsement

TIPRANKS
·
27 Dec 2024

Fennec announces Pedmarqsi positive recommendation by NICE

TIPRANKS
·
20 Dec 2024

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

GlobeNewswire
·
20 Dec 2024